Seoul, South Korea

Jae-Young Koh

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 9.4

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2004-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jae-Young Koh: Innovator in Diagnostic and Therapeutic Technologies

Introduction

Jae-Young Koh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of diagnostics and therapeutics, particularly in relation to protein aggregation and neuroprotective compounds. With a total of 5 patents, his work has the potential to impact various medical conditions.

Latest Patents

One of his latest patents is a diagnostic kit for the diagnosis of abnormal protein aggregation or misfolding-related diseases. This innovative kit is designed to accurately diagnose disorders related to abnormal protein aggregation, including Alzheimer's disease, by analyzing the concentration of aggregated proteins before and after dissociation. Another notable patent involves novel dialkylhydroxybenzoic acid derivatives containing metal chelating groups. These compounds are aimed at treating and preventing medical dysfunctions arising from reactive oxygen species and excess zinc ions, showing promise in conditions such as stroke and Parkinson's disease.

Career Highlights

Throughout his career, Jae-Young Koh has worked with esteemed organizations such as Samsung Electronics and the Korea Institute of Science and Technology. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

He has collaborated with notable colleagues, including Sung-Bo Ko and Eu-Gene Oh, further enhancing the impact of his work in the scientific community.

Conclusion

Jae-Young Koh's contributions to the fields of diagnostics and therapeutics highlight his role as a leading inventor. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…